US · XRAY
DENTSPLY SIRONA Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Charlotte, NC 28277-3607
- Website
- dentsplysirona.com
Price · as of 2025-12-31
$11.81
Market cap 2.93B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $20.61 | +74.51% |
| Intrinsic Value(DCF) | $5.72 | -51.57% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $32.63 | $45.64 | $0.87 | $3.19 | $37.55 |
| 2012 | $36.33 | $49.70 | $0.36 | $7.74 | $50.64 |
| 2013 | $40.06 | $50.12 | $0.00 | $9.08 | $19.52 |
| 2014 | $43.45 | $61.90 | $0.00 | $9.07 | $16.34 |
| 2015 | $54.88 | $62.88 | $0.88 | $7.19 | $0.17 |
| 2016 | $55.08 | $67.99 | $5.62 | $15.33 | $91.48 |
| 2017 | $50.38 | $35.99 | $0.00 | $0.00 | $0.00 |
| 2018 | $42.78 | $32.50 | $0.00 | $0.00 | $0.00 |
| 2019 | $39.68 | $43.67 | $0.00 | $7.90 | $10.21 |
| 2020 | $56.32 | $45.63 | $0.64 | $0.00 | $2.71 |
| 2021 | $43.99 | $54.33 | $1.09 | $7.76 | $63.54 |
| 2022 | $33.79 | $28.41 | $0.00 | $0.00 | $0.00 |
| 2023 | $31.36 | $31.60 | $0.00 | $0.00 | $0.00 |
| 2024 | $15.56 | $17.35 | $0.00 | $0.00 | $0.00 |
| 2025 | $14.31 | $20.61 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates DENTSPLY SIRONA Inc.'s (XRAY) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $20.61
- Current price
- $11.81
- AI upside
- +74.51%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$5.72
-51.57% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| XRAY | DENTSPLY SIRONA Inc. | $11.81 | 2.93B | +75% | -52% | — | — | -4.77 | 2.13 | 0.78 | -107.57 | — | -3.65 | 50.00% | 6.85% | -16.25% | -36.44% | 6.83% | -10.70% | 1.81 | 2.86 | 1.51 | 0.76 | -45.54 | -3304.00% | -298.00% | -6299.00% | 3.64% | 0.17 | 2.82% | 4.49% | -21.40% | 4.49% | 19.64 | 47.58 | 1.34 | 1.00 |
| AGIO | Agios Pharmaceuticals, In… | $30.23 | 1.77B | -31% | +212% | — | — | -4.10 | 1.42 | 31.33 | -1.93 | — | 1.42 | 88.26% | -873.87% | -764.01% | -30.20% | -85.25% | -27.89% | 0.05 | — | 11.46 | 10.52 | 0.06 | -16117.00% | 4803.00% | -364.00% | -22.29% | -4.54 | -68.29% | 0.00% | 0.00% | 0.46% | -1.91 | -2.39 | 16.67 | 8.79 |
| BEAM | Beam Therapeutics Inc. | $28.46 | 2.89B | +40% | +284% | -70% | — | -35.47 | 2.29 | 20.31 | -63.04 | — | 2.29 | 84.05% | -274.57% | -57.24% | -8.11% | -231.66% | -6.19% | 0.24 | -8.77 | 13.09 | 12.85 | 0.04 | -8231.00% | 12001.00% | 108.00% | -12.69% | -3.56 | -217.38% | 0.00% | 0.00% | 0.00% | -4.92 | -5.24 | 13.50 | 5.65 |
| BHC | Bausch Health Companies I… | $5.93 | 2.2B | +958% | +67% | — | +6% | 18.37 | -3.99 | 0.21 | 7.14 | — | -0.13 | 68.33% | 20.07% | 1.51% | -13.10% | 4.28% | 0.45% | -38.35 | 1.37 | 1.47 | 0.88 | 6.42 | -41538.00% | 711.00% | -2040.00% | 45.49% | 0.34 | 5.18% | 0.00% | 0.00% | 34.48% | 10.68 | 22.02 | 2.14 | 0.28 |
| CON | Concentra Group Holdings … | $23.96 | 3.07B | +123% | -60% | — | +21% | 17.38 | 7.64 | 1.39 | 8.47 | — | -2.26 | 28.34% | 96.50% | 7.99% | 51.66% | 111.32% | 6.42% | 1.37 | 19.10 | 1.14 | 1.00 | 1.12 | 0.00% | 1385.00% | 3283.00% | 9.30% | 0.83 | 19.29% | 0.00% | 0.00% | 43.58% | 1.66 | 12.39 | 1.60 | 4.00 |
| HAE | Haemonetics Corporation | $63.32 | 2.96B | -0% | -52% | -67% | -37% | 21.15 | 4.32 | 2.61 | 12.54 | 47.48 | -14.83 | 57.21% | 16.30% | 12.32% | 18.83% | 10.54% | 7.22% | 1.49 | 22.76 | 1.62 | 0.88 | 2.58 | 4454.00% | 395.00% | 2338.00% | 4.02% | 0.31 | 8.56% | 0.00% | 0.00% | 6.34% | 20.13 | 31.34 | 3.28 | 2.54 |
| ICUI | ICU Medical, Inc. | $150.58 | 3.72B | -14% | -61% | -83% | -100% | 4947.86 | 1.71 | 1.62 | 14.41 | — | -381.73 | 36.76% | 4.80% | 0.03% | 0.04% | 1.32% | 0.02% | 0.66 | 1.01 | 2.36 | 0.98 | 3.32 | -10061.00% | -638.00% | -2636.00% | 2.53% | 0.36 | 2.82% | 0.00% | 0.00% | 7.11% | 44.00 | 51.26 | 2.11 | 2.21 |
| LMAT | LeMaitre Vascular, Inc. | $108.18 | 2.45B | -46% | -51% | -89% | -62% | 41.10 | 5.37 | 8.23 | 25.41 | 93.35 | 7.69 | 68.63% | 23.77% | 20.03% | 13.87% | 18.60% | 9.80% | 0.55 | 254.91 | 13.14 | 10.77 | 2.40 | 4403.00% | 1363.00% | 2603.00% | 2.05% | 1.44 | 17.08% | 0.79% | 32.60% | 0.79% | 32.46 | 45.64 | 7.71 | 6.95 |
| QDEL | QuidelOrtho Corporation | $22.74 | 1.54B | -6% | -60% | — | — | -1.35 | 0.80 | 0.56 | -8.47 | — | -2.38 | 46.67% | -33.67% | -41.45% | -46.15% | -18.22% | -18.56% | 1.46 | -5.18 | 1.50 | 0.64 | -5.40 | -4535.00% | -189.00% | -2596.00% | -5.42% | 0.11 | -1.65% | 0.00% | 0.00% | 0.00% | -4.50 | -49.82 | 1.51 | 0.29 |
| RXRX | Recursion Pharmaceuticals… | $3.67 | 1.47B | +586% | +721% | — | — | -2.52 | 1.44 | 21.75 | -1.71 | — | 2.47 | -61.96% | -867.87% | -863.35% | -59.54% | -127.75% | -44.12% | 0.07 | -358.08 | 5.50 | 5.20 | 1.19 | -1479.00% | 2692.00% | 145.00% | -23.29% | -2.52 | -74.58% | 0.00% | 0.00% | 11.05% | -1.48 | -2.53 | 12.84 | 0.01 |
| WRBY | Warby Parker Inc. | $25.01 | 3.06B | +69% | -49% | -88% | -99% | 1965.26 | 8.77 | 3.70 | 59.48 | — | 8.77 | 53.97% | -0.61% | 0.19% | 0.46% | -0.92% | 0.23% | 0.63 | — | 2.35 | 1.93 | -1.00 | -10771.00% | 1304.00% | 2600.00% | 1.36% | 0.74 | 13.98% | 0.00% | 0.00% | 0.76% | -594.41 | 72.52 | 3.64 | 5.67 |
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
- CEO
- Daniel T. Scavilla
- Employees
- 14K
- Beta
- 1.02
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($5.72 ÷ $11.81) − 1 = -51.57% (DCF, example).